LEHNQ Discussion 08/18/2014 08:30:12 $LEHNQ It's all

New Post Public Reply Private Reply Replies (0) Message Board
Jake13
LEHNQ Discussion 08/18/2014 08:30:12 $LEHNQ
It's all interpretation, but words matter imo .

Quote:
Quote:
Under the new Lehman plan, holders of unsecured debt from the parent company would receive 21.1 cents on the dollar, down from 21.4 cents under the January plan. Other unsecured creditors would get 19.9 cents on the dollar.

Creditors such as Paulson earlier sought roughly 24 cents on the dollar.

Many unsecured creditors of the Lehman Brothers Special Financing Inc derivatives unit would receive 27.9 cents on the dollar. These creditors include large banks that had been Lehman trading partners, as well as hedge funds.

Holders of commercial paper, a type of short-term debt, could recover 48.4 cents or 55.7 cents on the dollar.

Lehman has said creditors have roughly $322 billion of allowed claims, meaning they would on average recover about 20 cents on the dollar.


Allowed claims 322bil. Pro rata clauses after Allowed claims satisfied in full.


For Newbies

LEHNQ, LEHLQ, LHHMQ, LEHKQ
All in the same boat...


,,,,,,,Good Morning guys. MERRY CHRISTMAS FROM UNCLE SAM.
You made me confused again on your question. If you are looking and referring on due to affiliates on the balance sheet table, then you are looking at the wrong place. Those due from and due to affiliates at not the claims. Those are indeed inter company balances.

The claim that you should be looking at is the subject to compromise that only gives you a total.
Yes now you know what i am looking at and believe me i can read it and understand it very well

but i still want to you to go through it again and shed more light on my request (i will copy it and paste it here again)


"toogood have you noticed the Affiliate and the Affiliate Guarantee claims against LBHI (which are higher class of course than 10B)?? they are adding up to the 200B liabilities that you and Gus always talk about right?? where are these claims going to at the end??mmmmm? and check the same against LCPI,LBSF and others....those (or most of them) don't go as receivables at the end to LBHI??mmmmm??"
Follow up;

Remember, this is a rough estimate because the numbers are only from the distribution table that does not include other things or expenses.

Anyway, those numbers are good enough to see that there is a huge amount of deficit.


It will be more accurate if we used the balance sheet table.





Ana, I see now where you looking at. It is the claims update table in page 29.

The table will show you the claim is 341.2B, less 65.3B distribution.. The net claim is 275.9B.

Like I said on my first reply, The fifth distribution is not yet reflected in March. So you have to add about 16B to the distributed 65.3B, equals to 81.3B. Then you subtract the 81.3B to 341.2B, equals to net claim of 259.9B.

The deficit then is 259.9B minus remaining asset of about 43B, that will give you a deficit of about 216.9B.



I can't get what you meant. Are you looking at the balance sheet itself?

The balance sheet will show you that the remaining asset (balance)is a negative of more than 200B or 224B ( I don't have it in front of me). It is the difference between asset and liability. You also have to put the fifth distribution of about -16B into account because it is not reflected yet in March.

Let me know if you understand what I'm saying.
















Toogood maybe it was not 200B after all!!! or at least great amount was just "Funny Money"



insert-text-here
That is peculiar.....I wonder what their plans are also.
daisy, not sure, but, in one of cottons posts it was stated, I will guess july 15th.
Anyway thats close enough.

This is turning out to be one caraaaazy play.

My wand wave to me before siegfried and roy show up with one of thier tigers.


BTW!!!! THIS POST JUST PUSHED US TO SPOT 3 ON THE HOTTEST BOARDS


wand wave, wand wave, wand wave, wand wave.
Insider trading?

Typical...reminds me of wamu

Anyway, if this is the case, CTS are probably golden with JPM behind the scenes working the strings.
Its either you in or you are out at this point. We all talked all the scenarios to death and the remaining ones are the ones who are in for the NOLs. NOLs are going to be huge. There is really not much more new to say except NOLS NOLS NOLs.
My seat belt is fasten in the ac Gus bus... To da moon guster.
This really looks compelling there might be a sep/oct distribution to 10B/CTS:

Any insight on the cut off or record date to qualify for the upcoming distribution? The record date may have already closed explaining the lack of upward price movement on the CTS.

Even if the cut off date closed and buyers starting today won't be able to participate in a sep/oct distribution, the official notice (btw way this notice is posted on Lehman's epiq system), considering there will be expected future payments! It may be worthwhile to snag some more shares at this price level as a speculative investment imo!

Correction --- to CTS, not OBS
over 14,500 reads today, that is crazy!!!
I'm not sure where this comes from, we are a small group that knows the payout is near..
Who let the cat out of the bag?

gonna get some big money in the next two months!!!

top 5 now..!

Isn't it also worth bolding the sentence that follows?...

“That such a distribution is even possible represents an extraordinary achievement that was far from certain when the liquidation began. We expect additional distributions to unsecured general creditors, while maintaining appropriate reserves and protecting claimants’ interests and due process rights.”

That's the kicker imo. We expect ADDITIONAL distributions to UNSECURED creditors... Warrants a wow in my book.

This could be proof of my conspiracy theory that those senior creditors who had rights to vote on the POR also loaded their boats with unsecured debt that was trading at pennies on the dollar. They agreed to what appeared like a 75% hair cut at the senior/higher debt level (or no hair cut at the secured level) and then did the unspeakable, diverted the remaining assets from other senior/higher debt holder who agreed to satisfied in full at 17-30% recovery rates. We're dealing with mega billions here; I don't believe those debt holders who formed majority approval of POR just two years ago are currently scratching their heads asking "how did this happen?! Recovery for unsecured creditors?!" Heck.... They ARE the unsecured creditors, perhaps even OBS stakeholders, that will make off like bandits at the expense of other dumbfounded senior creditors who are dissatisfied to now be "satisfied in full"

Lesson learned: This isn't a case of big fish eats little fish...closer to fast fish eats slow fish...but more precisely conniving fish eats dumb fish... Lol

Hope we can ride the coat tails of these conniving fish.

Long live CTS, preferreds, and commons.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 269

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
China's 15th Plan: Key Moves in the Capital Markets

Updated Category News Views 127

Riding the Waves of Reform in China The winds of change are blowing through China's capital markets, and Guosen Securities is putting a stake in the ground with bold priorities for the 15th Five-Year Plan. As far as I'm concerned, the headlines here are thick with implications for anyone eyeing a piece of China's economic pie from 2026–2030. The Pillars of Stability and...

Continue Reading
CStone's CS2009: A Leap in Cancer Treatment Validated

Updated Category News Views 59

CStone's Game-Changer: CS2009 in the Spotlight CStone Pharmaceuticals just pulled a rabbit out of a hat at the ESMO 2026 Congress, showcasing the clinical might of their CS2009. This ain't just another hype train, folks. We're talking about a trispecific antibody targeting PD-1, VEGF, and CTLA-4. With data rolled out from over 300 patients, this compound promises a...

Continue Reading
NOTHING NINE's Global Ambitions: Paris Show's Impact

Updated Category News Views 83

Paris: Stage or Launchpad? You’d think walking that catwalk in Paris is the holy grail—fashion's own illustrious red carpet. But when you're Chloe, founder of NOTHING NINE, the real hustle kicks off once the lights dim. On 29th September 2026, this designer brand strutted its stuff at one of the grandest venues, Les Invalides, part of the prestigious Paris Fashion...

Continue Reading
Ambient AI Shows Promise for Boosting Cancer Care Efficiency

Updated Category News Views 13

Study Points to Ambient AI's Promise in Oncology Some days, the world of cancer care is a real beast to tackle. But today, we've got a glimpse into how technology, and specifically ambient AI, might just help slay some of the burdens that these healthcare warriors face daily. The Florida Cancer Specialists & Research Institute (FCS) joined hands to dive into how this tech...

Continue Reading
Superteam Wheels Rides Into Spain with RACEIT Deal

Updated Category News Views 63

Rolling Out the Red Carpet for Spanish Cyclists Think of it as the pedal-powered bridge from wherever Superteam Wheels calls home to the sunny streets of Spain. If you're in the cycling game, this new partnership between Superteam Wheels and COMERTECH RACEIT, S.L., better known as RACEIT, is drawing a line in the sand—or perhaps on the asphalt—across Europe. Starting...

Continue Reading
Zinzino Eyes European Market With New Botanical Line

Updated Category News Views 98

Zinzino's Strategic Play in Europe's Wellness Market There's a new player on the European wellness block, and it's Zinzino's latest concoction of fermented botanical supplements. This isn't just your run-of-the-mill vitamin shop stock; we're talking about a lineup crafted for distinct parts of the day, reflecting an evolving consumer trend. People are looking for tailored...

Continue Reading
HCLTech Partners with Rapidus on Semiconductor Future

Updated Category News Views 81

Making Sense of the HCLTech and Rapidus Collaboration When you're talking about the world of semiconductors, no two words get tossed around more than innovation and speed. Now, with the recent partnership between HCLTech and Rapidus, those words are bound to echo from India to Japan and beyond. We have HCLTech, a stalwart of global technology, teaming up with Rapidus, a...

Continue Reading
ASICS and University of Michigan Launch Innovation Lab

Updated Category News Views 88

Running Innovation Gets a Boost in Ann Arbor On a crisp fall day up in Ann Arbor, ASICS and the University of Michigan have decided it's high time to shake up the world of running product R&D. These two powerhouses just launched the ASICSx Michigan Sport Innovation Center (AMSI), an academic-industry research lab. It's like they're mixing college smarts with business...

Continue Reading
Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 412

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading

Top 5 Most Recently Viewed Articles

TuHURA Biosciences Advances Phase 3 Trial for Cancer Treatment

Updated Category News Views 229

TuHURA Biosciences Moves Forward with Phase 3 Trial TuHURA Biosciences, Inc. (NASDAQ: HURA) is making substantial strides in the field of cancer immunotherapy. The company is geared up to launch its Phase 3 accelerated approval trial of IFx-2.0, a promising adjunctive therapy in combination with Keytruda (pembrolizumab), targeting advanced and metastatic Merkel cell...

Continue Reading
Fiserv, Inc. Lawsuit: Investors Can Fight Back Against Losses

Updated Category News Views 198

Introduction to the Class Action Lawsuit In recent news, numerous investors in Fiserv, Inc. are being alerted to an important opportunity. A class action lawsuit has been initiated targeting Fiserv, a prominent figure in the financial services tech sector. This situation arises from allegations of significant financial losses endured by shareholders due to the Company's...

Continue Reading
Exploring Humana's Decreased Short Interest and Market Impact

Updated Category News Views 104

Understanding Humana's Short Interest Trends Recently, Humana Inc (NYSE: HUM) has reported a notable decline in its short percent of float, decreasing by 6.3% since the previous report. As of now, the company has approximately 4.30 million shares sold short, which constitutes about 3.57% of the total shares available for trading. Based on the current trading volumes, it...

Continue Reading
Innovative Restaurant Launch Featuring AI Robots Opens Soon

Updated Category News Views 344

AI-Driven Restaurant Opening at Walmart Supercenter In an exciting development for the dining industry, Richtech Robotics Inc. (NASDAQ: RR), a leader in AI-driven service robots, has joined forces with Ghost Kitchens America to unveil their latest One Kitchen restaurant. This location, situated within a Walmart Supercenter, is marking a significant milestone as it becomes...

Continue Reading
Choosing the Perfect MySmile Teeth Whitening Solution for You

Updated Category News Views 82

Your Guide to MySmile Teeth Whitening Products Achieving a whiter, brighter smile is easier than ever with MySmile's effective teeth whitening solutions. MySmile offers a range of products tailored to fit different lifestyles; whether you're interested in an all-in-one kit, convenient whitening strips, or one-step solutions, the right product is just a choice away. Let's...

Continue Reading